Results per Page:
Mutations remain one-in-a-million after HCT
From the Storb Group, Clinical Research Division
Untangling how body location promotes cancer
Beronja Lab postdoc Rachel Lex receives ACS fellowship to uncover regional factors driving tumor development
'Something everyone can get': New spinoff to commercialize cord blood stem cell therapies
New Fred Hutch spinoff to commercialize cord blood stem cell therapies based on work by Drs. Colleen Delaney, Irwin Bernstein